PAK LAW GPT — Pakistan Case Law AI justice scale emblemPAK LAW GPTCase law · Urdu & English

SHOW-CAUSE NOTICE ISSUED TO M/S 3N-LIFEMED PHARMACEUTICALS vs M/S — 2025 CLD 193 COMPETITION COMMISSION OF PAKISTAN

Case information

Citation
2025 CLD 193 COMPETITION COMMISSION OF PAKISTAN
Year
2025
Reporter
CLD
Parties
SHOW-CAUSE NOTICE ISSUED TO M/S 3N-LIFEMED PHARMACEUTICALS vs M/S
Provisions referred to
S. 59---D; S. 59; Pakistan Act (XXI of 2012); Competition Act; Pakistan Act

Fields are extracted from the reported citation and judgment text. Where a detail is not stated in the record, it is not shown.

Judgment text as reported

SHOW-CAUSE NOTICE ISSUED TO M/S 3N-LIFEMED PHARMACEUTICALS VS M/S. RENACON PHARMA LTD. FOR DECEPTIVE MARKETING PRACTICES S. 59---Drug Regulatory Authority of Pakistan Act (XXI of 2012), Preamble---Deceptive marketing practice---Competition Commission of Pakistan---Jurisdiction---Overriding effect---Provision of S. 59 of Competition Act, 2010 is non-obstante clause and no such provision exists in Drug Regulatory Authority of Pakistan Act, 2012---Commission could take cognizance of matters that include deceptive marketing practices, notwithstanding anything to the contrary contained in any other law on the subject-matter---DRAP does not have jurisdiction over the subject matter and Drug Regulatory Authority of Pakistan Act, 2012 does not impose any bar on exclusive mandate of Commission to prohibit and penalize deceptive marketing practices caused by false or misleading dissemination of information.

Other judgments reported in 2025 CLD

Back to the case-law library · Search Pakistani case law in Urdu or English